/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
18F-FDG perfusion-metabolism mismatch 3 days after acute myocardial infarction predicts worse outcome: molecular glucose steel phenomenon visualized by hybrid PET-MRI images
Event: ESC Congress 2019
Topic: Hybrid and Fusion Imaging
Session: Nuclear cardiology: from bench to bedside
The myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart
Event: ESC Congress 2019
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Treatment of heart failure
Heart failure with reduced ejection fraction is characterized by systemic NEP downregulation
Event: Heart Failure 2019
Topic: Experimental Heart Failure
Session: Basic Science and Translational
Role of neprilysin in myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart
Event: Heart Failure 2019
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Rapid Fire 2 - Biomarker: present and future
Therapeutic response of peritoneal dialysis as a therapy for refractory heart failure and congestive right ventricular dysfunction
Event: Heart Failure 2018
Topic: Treatment, Other
Session: Chronic Heart Failure – Treatment
Circulating Neprilysin is not a prognostic biomarker for cancer patients
Event: Heart Failure 2018
Topic: Biomarkers
Session: Chronic Heart Failure – Diagnostic Methods
Extreme RAS regulation in HFrEF already on optimal treatment: the low and high renin phenotype heart failure
Event: ESC Congress 2017
Topic: Pharmacologic therapy
Session: Chronic heart failure (CHF)
ESC 365 is supported by
